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Abstract
Background: The adequacy of pre-procedure preparation is the principal determinant of the quality of
colonoscopy in pediatric as in adult patients. There is a lack of consensus, among providers on a standard preprocedure regimen. Professional society guidelines include the use of Polyethylene glycol (PEG). Herein we report
on the provider-assessed adequacy of a one day, age-categorized dosing, PEG based cleanout regimen in children
undergoing colonoscopy in a tertiary institution.
Methods: The standard bowel preparation regime at our institution includes an age dependent minimum PEG
dosing regimen in addition to clear liquids the day prior to the procedure. We retrospectively abstracted
relevant indices including patient demographics, prep quality, procedure impairment, duration and completion
from an institutional quality monitoring survey tool between 2015 and 2016 and similarly abstracted
prospectively recorded indices that included the dataset above as well as additional fields for procedure
deviations and additional laxative use.
Results: A total of 642 procedures (mean age 12.2 years; F: 380) were accrued, nonadherence to the cleanout
regimen (7.3%) and additional laxative use (3.1%) were observed in a small proportion of the prospective
dataset subjects, adequate cleanout defined as thin or thick liquid but no solids present was reported in 79.
5% and 15.8% of cases and impaired study from inadequate cleanout was reported in 11.8% of studies albeit
the cecum was reached and the terminal ileum was intubated in 97.8 and 93.6% of studies. The duration of
the study was significantly longer with the presence of a fellow trainee assisting in the procedure. Patient
age and gender did not correlate with prep adequacy or cecal and ileal intubation rates, inadequate cleanout
was significantly associated with impairment and incomplete studies.
Conclusion: A one day, single agent, osmotic laxative (Polyethylene glycol) based cleanout regimen is
effective in routine pre-procedure cleanout for standard colonoscopy in pediatric age range patients.
Keywords: Pediatric, Colonoscopy, Preparation, Cleanout, Quality, Polyethylene glycol

Background
The adequacy of colon cleansing before colonoscopy is a
principal determinant of the quality of colonoscopy in the
pediatric as in the adult population. Of the several determinants of bowel prep including regimen, timing, diet,
co-morbidities, and patient characteristics, preparation
regimen is by far the most important predictor of successful procedure outcomes [1]. Among the many preparation
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regimens available, Poly-Ethylene-Glycol (PEG), an osmotic laxative, is the primary choice for bowel prep, with
demonstrated safety and efficacy in children [2, 3]
However, with several other regimens reporting comparable efficacy, no standard protocol exists for
pediatric bowel prep.
A common alternative to PEG monotherapy for bowel
prep is dual therapy with a stimulant (bisacodyl, senna)
or combined stimulant–osmotic (Magnesium Citrate)
laxative, which directly affects nerve, smooth muscle,
and epithelial cells in the intestine to alter mucosal
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electrolyte transport [4]. A 2014 review by NASPHGHAN found that while PEG was the regimen of choice
for monotherapy, dual therapy with PEG and stimulant
laxative was used by between 36% (age 2–5 cohort) and
61% (age 12+ cohort) of physicians [5].
Stimulant laxatives, when used in the context of colonoscopy preparation are often associated with adverse
outcomes including bloating, cramps and abdominal discomfort [4], and are even contraindicated in certain patient populations, including patients with renal disease,
bowel obstruction, and those at risk for dehydration or
electrolyte imbalance [6]. In the treatment of pediatric
constipation, stimulant laxatives are recommended as a
second-line therapy if a PEG-only regimen fails [7]. Despite these important caveats, stimulant laxatives remain
a popular choice for dual-therapy bowel prep in
pediatric colonoscopy.
The purpose of this study is to report the experience
with a one day PEG-only bowel prep regimen in a
pediatric cohort of patients studied at a tertiary pediatric
gastroenterology service.

Methods
Children’s Mercy Hospital in Kansas City MO, is tertiary, urban, standalone children’s hospital with dedicated inpatient and ambulatory gastroenterology
services. Standard bowel prep protocol for all patients
undergoing elective outpatient colonoscopy during the
study period at this institution involved a one day
age-based graduated dosing schedule of PEG3550 (Miralax©; 17 g/240 mL/dose) Patients were instructed to take
1 dose every hour for a minimum of 6 (< 4 years) – 10
doses, with additional doses as needed to return clear
stool free of particulate matter. Dietary recommendations included clear liquids including electrolyte rich and
non-red colored liquids through 2 - 4 hours
pre-procedure all day or after breakfast (< 4 years age)
the day before the scheduled procedure. All colonoscopies are tracked with an institutional ethical practice
review approved survey instrument completed by the
endoscopy staff, including providers immediately following the procedure. The survey includes patient demographics, prep quality, impairment, duration, and
completion. A single abstractor reviewed data from all
pediatric patients (age 0 – 20) who presented to our GI
outpatient clinic for colonoscopy from September 2015
– September 2016 and were given standard PEG monotherapy. Cases in which > 1 of three primary outcomes
measures (procedure duration, completion, impairment)
were absent were excluded from the final sample.
Additionally, prospective data was collected on patients who presented to the GI outpatient clinic from
October 2016 – January 2017 with otherwise identical
inclusion and exclusion criteria using a slightly modified
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abstraction form. Prospective data included an additional
field to record procedure deviations where secondary
stimulant laxative was added. To characterize outcomes
in PEG-only prep, deviations from prep protocol, including the use of additional laxatives and patient
non-compliance, were excluded from the final analysis.
Outcomes of interest included quality of prep, procedure impairment, completion, and duration (defined
as scope-in to scope-out). Quality of prep was categorized as; thin liquid, thick liquid, and solid matter.
Impairment was recorded as a binary variable, based
on physician assessment of bowel prep. Completion
was measured as a binary variable for two levels –
reaching cecum and terminal ileum when ordered.
Additionally, retrospective data included a binary
variable for the presence of GI Fellows. All binary
variables were compared using Chi-Square Test. Procedure duration was compared between procedures
performed by attending physicians and fellows using a
Fischer Exact Test. Additionally, procedure duration
was compared between first, second and third year
fellows using a one-way ANOVA. P-value of 0.05 was
used as a threshold of significance.

Results
Retrospective data is summarized in Table 1. A total of
519 cases met all inclusion and exclusion criteria. Average age was 12.1 ± 4.2 years, with a male to female ratio
of 0.64:1. Since cases were only excluded if > 1 primary
outcome data field was missing, the total number of
cases in each field represents those for which a response
was submitted. There were no significant differences between age groups in terms of thin liquid (p = 0.241),
thick liquid (p = 0.913), impairment (p = 0.783), reaching
cecum (p = 0.485), or duration (p = 0.243). Significant
differences were found in solids (p = 0.001) and reaching
TI (p = 002).
Prospective data is summarized in Table 2. A total of
137 cases met inclusion criteria. 10 subjects were
non-compliant with bowel prep regimen, while 4 other,required additional stimulant laxatives due to perceived
poor prep. These cases were excluded from the final
analysis. Table 3 summarizes the differences in procedure metrics based on prep quality, and found significant
differences in procedure impairment (p < 0.001), reaching cecum (< 0.001), reaching TI (< 0.001), and procedure duration (0.011).
A summary of Fellow procedure duration is provided
in Table 4. Of a total of 439 recorded cases, 299 were
performed by attending physician only, while 140 were
performed by a GI fellow with an attending physician
present. Table 3 also summarizes differences in procedure duration between first, second and third year trainee
fellows. The p value for both comparisons was < 0.0001.
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Table 1 Quality of cleanout by age at the time of endoscopy: retrospective cohort
Age

Total

Sex (M)

Quality

Completion

Thin Liquid

Thick Liquid

Solid

Impairment

Cecum Reached

TI Reached

Duration
(Mean ±
SD)

1–5

47

21 (44.7%)

27 (57.4%)

5 (10.6%)

7 (14.9%)

6 (12.8%)

42 (89.4%)

33 (100.0%)

21.6 ± 10.2

6–9

96

38 (39.6%)

68 (70.8%)

14 (14.6%)

3 (3.1%)

8 (8.3%)

93 (96.9%)

85 (96.6%)

21.4 ± 10.3

10–13

136

61 (44.9%)

102 (75%)

20 (14.7%)

2 (1.5%)

13 (9.6%)

129 (94.9%)

123 (94.6%)

24.6 ± 12.1

14–16

172

51 (29.7%)

121 (70.3%)

26 (15.1%)

9 (5.2%)

22 (12.8%)

162 (94.2%)

157 (94.0%)

23.4 ± 11.8

17–20

68

31 (45.6%)

50 (73.5%)

8 (11.8%)

1 (1.5%)

8 (11.8%)

64 (94.1%)

57 (95.0%)

23.0 ± 10.7

0.038

0.241

0.913

0.001

0.783

0.485

0.002

0.243

519

202

368

73

22

57

490

455

23.5 ± 11.9

p value
Measured
Total

519

519

463

463

463

482

501

486

439

Percent

100.00%

38.90%

79.50%

15.80%

4.80%

11.80%

97.80%

93.60%

NA

Discussion
The purpose of this study was to characterize outcomes in a
1-Day PEG-only bowel prep in a pediatric population;
pediatric gastroenterologists are generally split in their preference for PEG monotherapy or PEG-stimulant laxative dual
therapy for colonoscopy preparation (5). The results of this
study support the implementation of a one day PEG-only
regimen with high adherence rates and good quality preparation and excellent colonoscopy completion rates.
The choice of a prep strategy in children has to balance between the conflicting desire toward a pristine
cleanout with the disadvantages inherent to complex
regimens including poor adherence, discomfort from
dietary restrictions and poor adherence with complex
instructions. This equation in turn needs to be refocused
within the goals of colonoscopy in children which rarely,
if ever, include detection of small lesions or polyps as in
colon cancer surveillance and standard of care reliance
Table 2 Quality of cleanout by age at the time of endoscopy:
prospective cohort
Total

Measured

Total

Percent

123

123

100%

Demographics
Age (Mean ± SD)

13.0 ± 3.7

123

NA

Gender (M)

60

123

48.78%

Pre- procedure
reported constipation

8

123

6.50%

Non-Compliant

10

[137]

7.30%

Outcomes

Additional Laxative

4

[127]

3.10%

Impairment

6

123

4.88%

121

123

98.37%

27 ± 11.5

123

NA

Completion
TI Reached
Duration
Duration/minutes (Mean ± SD)

on biopsy based diagnosis which decreases the onus for
macroscopic assessment and high quality preparation.
Quality of prep with PEG-only prep was excellent.
Solids found in colon during procedure is generally associated with poor prep, while the presence of only thin or
thick liquids is considered adequate prep [8] . In our
retrospective data, thin liquids were found in 79.48% of
cases, thick liquids were found in 15.77% of all cases,
and solids were found in only 4.75% of recorded cases,
indicating overall adequate prep in > 95% of cases.
Physician-determined impairment due to poor prep was
noted in 11.8% of retrospective cases. Retrospective data
included cases with patient deviation from protocol and
additional stimulant laxative, and likely reflects expected
prep impairment in a practice setting. In the prospective
data, which included only protocol-adherent cases,
prep-related impairment was only 4.88%, again indicating adequate prep in > 95% of cases. Only 4 cases (3.1%)
required an alternative regimen. In all 4 cases, a parent
directly contacted GI clinic staff after partial completion
of the PEG regimen requesting additional laxative due to
perceived ineffectiveness. In a similar comparison of regimens for constipation in children, 18% of patients given
PEG monotherapy required additional laxatives [9].
Cleanout efficacy in our data is comparable to that of
other studies of PEG-only regimen, which found cleanout efficacy rates as high as 89% and 95% [10, 11]. Notably, these other studies utilized a 4-day PEG prep of
1.5 g/Kg, a significantly longer and more intrusive protocol. Achieving similar cleanout rates with a lower-dose,
one-day regimen is encouraging and significant. Additionally, patient adherence with regimen was also high;
with 7.3% of patients being non-compliant with the
assigned regimen. Decreased non-adherence rates compares favorably with other studies in which low volume
PEG prep was used, in contrast to higher non-adherence
found in studies using high volume PEG preparation,
which ranged from 38 to 46% [12, 13].
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Table 3 Impairment, completion of procedure and duration by quality of cleanout
Quality

Total

Impairment

Cecum

TI

Duration (Mean ± SD)

Thin Liquid

368

10/349 (2.9%)

352/355 (99.2%)

331/347 (95.4%)

22.2 ± 11.4

Thick Liquid

73

25/68 (36.8%)

70/71 (98.6%)

60/67 (89.6%)

26.4 ± 11.4

Solid

22

P value

13/19 (68.4%)

15/21 (71.4%)

13/19 (68.4%)

24.8 ± 6.9

< 0.001

< 0.001

< 0.001

0.011

Completion rates were also quite high, with cecum
and terminal ileum visualization in 97.80% and 93.60%,
respectively, in retrospective data, and terminal ileum
visualization at 98.37% in the prospective group, comparable to results in similar studies using larger volume
PEG prep solutions [12]. The results of this study are
significant in showing comparable quality, impairment,
compliance, and completion of prep in 1-day PEG bowel
prep and high-volume, multi-day prep. A number of past
studies have highlighted the contrast between superior
efficacy of high-volume PEG solution and low patient
tolerance and adherence to a multi-day, high-volume
PEG prep [2, 12, 14]. Other groups have attempted to
address this issue by exploring alternate delivery models
such as split-dosing and low-volume PEG with added
stimulant laxative [15–17].
Although the dominant alternative that has emerged
to high-volume PEG monotherapy is low-dose PEG with
stimulant laxative dual therapy, our observations suggest
that high volume PEG limited to one day pre-procedure
is effective and well tolerated. Further research is required to compare one day monotherapy with dual therapy in terms of safety, outcome based quality of prep,
adherence and tolerability [5].
There are several limitations to this study. Our study
focuses on an ambulatory care setting and our observations cannot be extrapolated to the inpatient setting. In
the retrospective data set, deviations from the standard
1-day PEG regimen were not consistently recorded, including introduction of another cleansing agent or completion of the minimum 10-doses. Given the identical
cleanout protocol,patient and provider population, we
can extrapolate from the prospective cohort data that
Table 4 Effect of fellow participation on procedure duration
# of Cases

Duration/minutes (Mean ± SD)

Total

439

23.5 ± 11.9

Attending Only

299

22 ± 11.1

Fellow

140

27.1 ± 12.6

p value

< 0.0001

Fellow Yr1

69

30.2 ± 13.5

Fellow Yr2

64

21.8 ± 9.0

Fellow Yr3

22

31.0 ± 14.0

p value

< 0.0001

the likelihood of stimulant laxative administration,
which is at least partially due to ineffective cleanout
is approximately 3% and this should be factored with
documented poor cleanout. Additionally, there were
significant differences between retrospective and prospective data in terms of mean procedure time. We
can partially attribute this discrepancy to differences
in fellow participation in the two cohorts. Evaluation
of impairment and poor prep due to cleanout protocol were ultimately subjective assessments made by
the attending physician at the time of procedure.
This may lead to significant variation in assessing
impairment between providers, as well as overestimation of impairment due to providers attributing
non-completion to prep quality rather than other factors such as technique. Another potential limitation
is the lack of safety data in the cleanout forms.
While this may be a significant exclusion, procedure
nursing staff in our institution recall no incidences of
medical or surgical adverse events related to cleanout
protocol.
As an academic institution with an accredited pediatric
fellowship program, we had the opportunity to analyze the
impact of fellow participation on the duration of the procedure. Procedures performed by fellows were significantly
longer (27.1 ± 12.6 min) than procedures performed by attending physicians only (22 ± 11.1 min), with a p < 0.0001.
This discrepancy can be attributed to several factors including the normal progression in technical expertise, the impact of direct supervision and discussion during the case as
well as the increased likelihood of fellows who are more advanced in their training to gravitate toward participating in
more complex cases in order to meet their training requirements as well as out of interest. There was, in fact a significant difference in procedure duration between PGY 4 (30.2
± 13.5 min), PGY 5 (21.8 ± 9.0 min), and PGY 6 (31.0 ±
14.0) fellows(p < 0.0001).

Conclusion
1-Day PEG monotherapy appears to be an adequate bowel
prep regimen for colonoscopy in the pediatric population.
Based on the comparable levels prep quality, compliance,
completion, of 1-Day prep with high-volume, multi-day
PEG prep and other combined laxative solutions, we do
not see the need for additional stimulant laxative to be
added to the bowel prep regimen.
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